In a move that will expand the boundaries of single-cell genomics, ROSALIND is excited to announce its partnership with CS Genetics, a leading innovator in genomics technology. Together, we aim to democratize access to single-cell research by combining the cutting-edge CS Genetics’ SimpleCell™ platform with ROSALIND’s powerful data analysis capabilities.
This strategic partnership brings together two key solutions: CS Genetics' revolutionary, instrument-free SimpleCell™ technology and ROSALIND's comprehensive multi-omics analysis platform. Researchers can now effortlessly integrate single-cell genomics into standard lab workflows, reducing the cost and complexity typically associated with such advanced research.
Enabling Faster and More Efficient Breakthroughs
At ROSALIND, we believe that empowering researchers with intuitive and accessible tools can lead to transformative discoveries. With CS Genetics' SimpleCell™, researchers can now expand the scale of their single-cell projects like never before. Our platform will provide the necessary infrastructure to interpret, collaborate, and derive insights from these experiments—accelerating time to discovery and increasing the return on investment for biopharma and academic research teams.
As Tim Wesselman, CEO of ROSALIND, explains:
"We’re thrilled to partner with CS Genetics because they’ve solved two key barriers to single-cell adoption: complexity and cost."
Democratizing Single-Cell Genomics
This partnership underscores our shared mission to make single-cell genomics more accessible and impactful for the global scientific community. With ROSALIND’s cloud-based, intelligent, no-code platform and CS Genetics’ simplified sample preparation, biopharma, academia, and clinical research teams can scale their work, pushing the frontiers of knowledge in single cell research.
ROSALIND is committed to empowering scientific teams with intuitive tools accelerates research across biopharma, academia, and clinical applications.
Together with CS Genetics, we are excited to usher in a new era for single-cell genomics, bringing this critical technology to the forefront of research and innovation. Click below to read the full press release.
